Concepts (135)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Administration, Intravenous
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Allergens
- Allergy and Immunology
- Ambulatory Care
- Amoxicillin
- Anaphylaxis
- Angioedema
- Angioedemas, Hereditary
- Angiotensin-Converting Enzyme Inhibitors
- Animals
- Anti-Bacterial Agents
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Anti-Inflammatory Agents, Non-Steroidal
- Antineoplastic Agents
- Antineoplastic Agents, Phytogenic
- Autoantibodies
- Autoantigens
- Autoimmunity
- beta-Lactams
- Biological Products
- Boston
- Bradykinin
- Bradykinin B2 Receptor Antagonists
- Capillary Leak Syndrome
- Carboplatin
- Cardiovascular Agents
- Child
- Child, Preschool
- Cisplatin
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase III as Topic
- Cohort Studies
- Combined Modality Therapy
- Complement C1 Inhibitor Protein
- Complement Inactivating Agents
- Cost of Illness
- Costs and Cost Analysis
- Cross-Over Studies
- Cross-Sectional Studies
- Cystadenoma, Serous
- Delayed Diagnosis
- Desensitization, Immunologic
- Diagnosis, Differential
- Diagnostic Tests, Routine
- Disease Management
- Disease Progression
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Evaluation, Preclinical
- Drug Hypersensitivity
- Electronic Health Records
- Electronics, Medical
- Excipients
- Faculty, Medical
- Female
- Follow-Up Studies
- Health Care Surveys
- Health Services Needs and Demand
- Hereditary Angioedema Types I and II
- Hospitals, General
- Humans
- Hypersensitivity
| - Hypersensitivity, Delayed
- Hypersensitivity, Immediate
- Hypotension
- Immunoglobulin E
- Immunoglobulins, Intravenous
- Incidence
- Infant
- Infant, Newborn
- Inflammation
- Infusions, Intravenous
- Injections, Subcutaneous
- Lymphoproliferative Disorders
- Male
- Middle Aged
- Nausea
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasms
- Ondansetron
- Outpatients
- Ovarian Neoplasms
- Paclitaxel
- Pandemics
- Patient Acceptance of Health Care
- Patient Satisfaction
- Patients
- Penicillins
- Peptides
- Personnel, Hospital
- Phenotype
- Physicians, Women
- Plasma Kallikrein
- Platinum Compounds
- Practice Guidelines as Topic
- Premedication
- Preventive Health Services
- Prospective Studies
- Quality of Health Care
- Quality of Life
- Referral and Consultation
- Remission Induction
- Retrospective Studies
- Risk
- Risk Assessment
- Risk Factors
- Rituximab
- RNA, Messenger
- Schools, Medical
- Self Administration
- Serotonin 5-HT3 Receptor Antagonists
- Severity of Illness Index
- Skin
- Skin Tests
- Surveys and Questionnaires
- Symptom Assessment
- Telemedicine
- Terbutaline
- Theophylline
- Time Factors
- Treatment Outcome
- United States
- United States Food and Drug Administration
- Urticaria
- Vaccination
- Vaccines, Synthetic
- Viral Vaccines
- Young Adult
|
Banerji's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_